Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...
Demand for its COVID vaccine has been waning since the pandemic, while adoption of its RSV shot - its second approved product- has been slower than expected, forcing Moderna to cut costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback